Membrane Wrap Lite
Commercial- Indications
- Wounds
Company intelligence / Profile preview
BioLab Sciences develops and commercializes advanced wound care and regenerative medicine products based on human amniotic tissues and fluids. Their portfolio includes membrane wraps for wound coverage, liquid allografts rich in cytokines/growth factors for tissue repair, and the MyOwnSkin™ system for autologous skin grafting. Products are terminally sterilized with no live stem cells. The company has achieved CMS reimbursement codes for some offerings. Clinical results are not detailed publicly but the company highlights broad adoption in wound care settings.
3 more assets in the full pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioLab Sciences.